Aug. 1, 2023

On August 1, 2023, Qurgen initiated a multicenter Phase I clinical trial of SON-DP in the United States for the treatment of all solid tumors. The trial is being conducted across the following clinical sites:

• MD Anderson Cancer Center
• Henry Ford Health System
• Carolina BioOncology Institute (CBI)
• Banner MD Anderson at Banner Gateway Medical Center
• Stephenson Cancer Center, University of Oklahoma.